ACE2 and COVID-19: It was recently demonstrated that exosomes from COVID-19 patients carry ACE2 receptors on its surface and that these vesicles can neutralize SARS-CoV-2 infection in humanized ACE2 (hACE2) transgenic mice by competing with the binding site of cellular ACE2 [50].